Navigation Links
New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting
Date:6/2/2008

ectable Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma (ECOG 5203)

Findings from this single-arm Phase 2 study provide encouraging data for the potential use of Nexavar in combination with docetaxel and cisplatin to treat patients with metastatic/advanced gastric/GEJ adenocarcinoma. The most common treatment-emergent adverse events included neutropenia, fatigue, anorexia, hand-foot reaction, nausea, diarrhea and dehydration.

The lead investigator for this study is Weijing Sun, MD, assistant professor of medicine, University of Pennsylvania, director of the Upper GI and Pancreatic-Biliary-Hepatic Cancer Group and the associate director of the GI Cancer Program. (abstract #4535).

Ovarian

Phase 2 Trial of Sorafenib in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

Preliminary findings from this Phase 2 study suggest that Nexavar is active and tolerated in patients with recurrent epithelial ovarian cancer. The most common treatment-emergent adverse events were dermatologic and metabolic.

The lead investigator for this study is Daniela Matei, M.D., Ph.D., assistant professor, department of medicine, Walther Oncology Center, Indiana University, Bloomington, IN. (abstract #5537).

"We continue to be encouraged by Nexavar's potential activity as a single agent or in combination with other chemotherapeutic agents in these early stage clinical trials in tumor types with high unmet treatment needs," said Susan Kelley, MD, vice president, Therapeutic Area Oncology, Bayer HealthCare Pharmaceuticals. "The more data we compile from various studies in multiple tumor types, the better informed we are to determine the appropriate direction for further development of Nexavar in additional clinical cancer settings."

Nexavar's Differentiated Mechanism

Nexavar targets both the tumor cell and tumor vasculature. In preclinical studies, Nexavar has be
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals, Inc.; OnyxPharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
2. Nexavar First FDA-Approved Drug Therapy for Liver Cancer
3. ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R)
4. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
5. Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting
6. Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments
7. New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
8. Data To Be Presented at ASCO Supports Potential of Peregrines Cotara(R) for the Treatment of Brain Cancer
9. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
10. Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
11. Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... HA,AYIN, Israel, December 15 EnzySurge ... the advanced chronic,wound management market, announced today ... Food and Drug Administration (FDA) to market ... FDA also cleared,DermaSept, an Over-the-Counter version of ... EnzySurge is the developer of the ...
(Date:12/15/2009)... University Hospital in Belgium, among the first hospitals ... arc therapy, has carried out its first treatment ... Varian Medical Systems ( VAR). A 56-year-old male ... seconds, over four times faster than possible using ... taken more than five minutes using conventional intensity-modulated ...
(Date:12/15/2009)... 15 Estill Medical Technologies, Inc., a family-owned ... and IV Fluid Infusion Warmer , a patented medical ... military and emergency responders to lessen ... CALSTAR 6 Unit of South Lake Tahoe as the ... Year Award." ,, CALSTAR is a California-based ...
Breaking Medicine Technology:EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution 2European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient 2European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient 3Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 2Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 3Thermal Angel Blood Warmer Recognizes CALSTAR 6 With Distinguished Emergency Responder Award 4New model of skin cancer provides insights on second most common type of cancer 63061 1New model of skin cancer provides insights on second most common type of cancer 63061 2NEI Awards a Two Year 242 18 Million SBIR Grant to Aciont 15142 1NEI Awards a Two Year 242 18 Million SBIR Grant to Aciont 15142 2NEI Awards a Two Year 242 18 Million SBIR Grant to Aciont 15142 3Edifecs Testifies Before NCVHS Standards Subcommittee Regarding HIPAA 5010 and ICD 10 Testing 63056 1Edifecs Testifies Before NCVHS Standards Subcommittee Regarding HIPAA 5010 and ICD 10 Testing 63056 2
(Date:12/15/2009)... Patient advocate Betsy McCaughey, Ph.D., will be cautioning ... matter whether there,s a public option. The current Senate ... give government authority over how your doctor treats you. ... by shifting billions of dollars from Medicare to handouts ... politicians." ,, Betsy McCaughey is the Founder/Chairman ...
(Date:12/15/2009)... American application activity for individually underwritten life insurance ... MIB Life Index(SM) . Solid growth ... months have lifted year-to-date (YTD) figures from their ... November,s close, -0.1%. "It is clear consumers ... from life insurance," says Stacy Gill, MIB Solutions, ...
(Date:12/15/2009)... A new study links chronic obstructive pulmonary disease, or ... sentinels to activate the body,s immune system. , ... to growing awareness of the immune system,s role in ... than 12 million Americans with wheezing, shortness of breath, ... key if doctors are to find better ways to ...
(Date:12/15/2009)... symptoms will call for help, experts say , , TUESDAY, ... reduced by teaching children how to spot the signs ... a new study shows. , Emergency medical treatment within ... the extent of brain damage and lead to better ... project included 515 sixth graders in Texas who were ...
(Date:12/15/2009)... new employment opportunity for the unemployed or those needing additional income... ... America today. , ... Orlando, FL (PRWEB) December 15, ... agencies, is spreading holiday cheer and good will that is going ... created an opportunity for out of work Americans to get back ...
Breaking Medicine News(10 mins):Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3Health News:Boosting Kids' Stroke IQ May Save Lives 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 3
... less than 2,000 grams (about 4.5 pounds) at birth ... the average teenager to have physical and mental difficulties, ... Archives of Pediatrics & Adolescent Medicine, one of the ... increase the risk for major disabilities such as cerebral ...
... soldiers seriously wounded or injured during combat in Iraq ... the risk for posttraumatic stress disorder (PTSD) and depression, ... The American Journal of Psychiatry, the official journal of ... Thomas A. Grieger, M.D., and colleagues at the Uniformed ...
... controversial crackdown on discount drugs mailed from Canadian pharmacies ... the plans of the federal government, thereby removing the ... ,The Department of Homeland Security, which operates the ... would stop the confiscation of Canadian drugs Monday and ...
... WASH - World Action on Salt and Health has been ... preventing over 2.5 million deaths a year.// ,194 medical ... pressurize food companies into reducing dietary salt intake to prevent ... coincides with a World Health Organisation summit in Paris to ...
... on the field is soon expected to be cut down ... ,NBC4's Dr. Bruce Hensel reported that the new screening program ... Italian athlete teen before he's allowed to play sports. This ... have apparent signs or symptoms. ,Dr. Gaetano Thiene ...
... million grant has been given to a dozen top ... set up a network// that would hasten scientific discoveries ... medical research is done. ,This idea came ... has made it more difficult than ever for scientists ...
Other Medicine News:Health News:Low Birth Weight Babies May Have Mental & Physical Problems 2Health News:US to Lift Ban on Canadian Drug Imports 2Health News:Food Makers Pressurized to Reduce Salt 2Health News:NIH Funds the Development of National Consortium of Universities 2
Weitlaner retractor, blunt....
Daubenspeck sharp curette, 8....
Ring curette, 4 mm 90 angle....
15" overall length, 5" handle....
Medicine Products: